| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Phreesia Inc (NYSE: PHR)
PHR Technical Analysis
1.5
| As on 9th Jun 2023 PHR STOCK Price closed @ 32.76 and we RECOMMEND Buy for LONG-TERM with Stoploss of 26.42 & Sell for SHORT-TERM with Stoploss of 33.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PHRSTOCK Price
| Open | 33.42 | Change | Price | % |
| High | 34.07 | 1 Day | -0.37 | -1.12 |
| Low | 32.70 | 1 Week | 2.74 | 9.13 |
| Close | 32.76 | 1 Month | 1.26 | 4.00 |
| Volume | 284600 | 1 Year | -11.42 | -25.85 |
| 52 Week High 44.76 | 52 Week Low 13.72 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| PHR Daily Charts |
PHR Intraday Charts |
Whats New @ Bazaartrend |
PHR Free Analysis |
|
|
PHR Important Levels Intraday
| RESISTANCE | 35.40 |
| RESISTANCE | 34.55 |
| RESISTANCE | 34.03 |
| RESISTANCE | 33.51 |
| SUPPORT | 32.01 |
| SUPPORT | 31.49 |
| SUPPORT | 30.97 |
| SUPPORT | 30.12 |
PHR Forecast May 2024
| 4th UP Forecast | 55.63 |
| 3rd UP Forecast | 48.3 |
| 2nd UP Forecast | 43.76 |
| 1st UP Forecast | 39.23 |
| 1st DOWN Forecast | 26.29 |
| 2nd DOWN Forecast | 21.76 |
| 3rd DOWN Forecast | 17.22 |
| 4th DOWN Forecast | 9.89 |
PHR Weekly Forecast
| 4th UP Forecast | 43.99 |
| 3rd UP Forecast | 40.39 |
| 2nd UP Forecast | 38.16 |
| 1st UP Forecast | 35.94 |
| 1st DOWN Forecast | 29.58 |
| 2nd DOWN Forecast | 27.36 |
| 3rd DOWN Forecast | 25.13 |
| 4th DOWN Forecast | 21.53 |
PHR Forecast2024
| 4th UP Forecast | 94.83 |
| 3rd UP Forecast | 74.92 |
| 2nd UP Forecast | 62.62 |
| 1st UP Forecast | 50.31 |
| 1st DOWN Forecast | 15.21 |
| 2nd DOWN Forecast | 2.9 |
| 3rd DOWN Forecast | -9.4 |
| 4th DOWN Forecast | -29.31 |
Phreesia Inc ( NYSE USA Symbol : PHR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PHR Business Profile
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was founded in 2005 and is headquartered in Raleigh, North Carolina. Address: 434 Fayetteville St, Raleigh, NC, United States, 27601
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service